- Home
- AQST vs LPTH Comparison
AQST vs LPTH Comparison
Compare AQST & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | LPTH |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.0M | 563.1M |
| IPO Year | 2007 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AQST | LPTH |
|---|---|---|
| Price | $4.21 | $14.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $9.00 | ★ $13.33 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | $37,202,630.00 |
| Revenue This Year | $10.08 | $83.04 |
| Revenue Next Year | $49.60 | $24.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.77 | ★ 17.26 |
| 52 Week Low | $2.22 | $1.92 |
| 52 Week High | $7.55 | $15.24 |
Technical Indicators
Market Signals| Indicator | AQST | LPTH |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 65.00 |
| Support Level | $3.70 | $9.60 |
| Resistance Level | $4.42 | $15.24 |
| Average True Range (ATR) | 0.15 | 1.15 |
| MACD | 0.01 | 0.41 |
| Stochastic Oscillator | 76.90 | 82.88 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.